Andrew Balog testifies at trial over allegations his firm, Greenberg Traurig, committed malpractice in representing Florida-based biotech firm Dyadic International.
West Palm Beach, FL—A Greenberg Traurig attorney this week defended his recommendation that a Florida biotech company halt trading of its stock because of anonymous accusations against its subsidiary, as trial continued over the company’s malpractice claim against the law firm. Dyadic Inc. v. Greenberg Traurig, 2009CA010680.